200 related articles for article (PubMed ID: 35836804)
1. Essential role of IL-17 in acute exacerbation of pulmonary fibrosis induced by non-typeable
Chen S; Zhang X; Yang C; Wang S; Shen H
Theranostics; 2022; 12(11):5125-5137. PubMed ID: 35836804
[No Abstract] [Full Text] [Related]
2. IL-17A contributes to HSV1 infection-induced acute lung injury in a mouse model of pulmonary fibrosis.
Chen T; Qiu H; Zhao MM; Chen SS; Wu Q; Zhou NY; Lu LQ; Song JC; Tang DL; Weng D; Li HP
J Cell Mol Med; 2019 Feb; 23(2):908-919. PubMed ID: 30378252
[TBL] [Abstract][Full Text] [Related]
3. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
[TBL] [Abstract][Full Text] [Related]
4. C-type lectin Mincle initiates IL-17-mediated inflammation in acute exacerbations of idiopathic pulmonary fibrosis.
Tao C; Xian H; Nian-Yu Z; Jia-Cui S; Dong W; Hui-Ping L
Biomed Pharmacother; 2023 Mar; 159():114253. PubMed ID: 36680813
[TBL] [Abstract][Full Text] [Related]
5. CSF3 aggravates acute exacerbation of pulmonary fibrosis by disrupting alveolar epithelial barrier integrity.
Guo B; Liu W; Ji X; Xi B; Meng X; Xie W; Sun Y; Zhang M; Liu P; Zhang W; Yan X; Chen B
Int Immunopharmacol; 2024 Jun; 135():112322. PubMed ID: 38788452
[TBL] [Abstract][Full Text] [Related]
6. The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis.
Hanaka T; Kido T; Noguchi S; Yamada S; Noguchi H; Guo X; Nawata A; Wang KY; Oda K; Takaki T; Izumi H; Ishimoto H; Yatera K; Mukae H
BMC Pulm Med; 2019 Dec; 19(1):265. PubMed ID: 31888585
[TBL] [Abstract][Full Text] [Related]
7. A New Model of Acute Exacerbation of Experimental Pulmonary Fibrosis in Mice.
Yegen CH; Haine L; Da Costa Ferreira K; Marchant D; Bernaudin JF; Planès C; Voituron N; Boncoeur E
Cells; 2022 Oct; 11(21):. PubMed ID: 36359778
[TBL] [Abstract][Full Text] [Related]
8. Development of a non-infectious rat model of acute exacerbation of idiopathic pulmonary fibrosis.
Chen SS; Yin ZF; Chen T; Qiu H; Wei YR; Du SS; Jin YP; Zhao MM; Wu Q; Weng D; Li HP
J Thorac Dis; 2017 Jan; 9(1):96-105. PubMed ID: 28203411
[TBL] [Abstract][Full Text] [Related]
9. A novel pulmonary fibrosis murine model with immune-related liver injury.
Jia K; Wu J; Li Y; Liu J; Liu R; Cai Y; Zhang Y; Li X
Animal Model Exp Med; 2023 Jun; 6(3):274-282. PubMed ID: 35934841
[TBL] [Abstract][Full Text] [Related]
10. Resolution of bleomycin-induced murine pulmonary fibrosis via a splenic lymphocyte subpopulation.
Kamio K; Azuma A; Matsuda K; Usuki J; Inomata M; Morinaga A; Kashiwada T; Nishijima N; Itakura S; Kokuho N; Atsumi K; Hayashi H; Yamaguchi T; Fujita K; Saito Y; Abe S; Kubota K; Gemma A
Respir Res; 2018 Apr; 19(1):71. PubMed ID: 29690905
[TBL] [Abstract][Full Text] [Related]
11. Acute exacerbation of idiopathic pulmonary fibrosis model in the rats using bleomycin and lipopolysaccharides.
Kurniawan SV; Louisa M; Zaini J; Surini S; Soetikno V; Wuyung PE; Uli RCT
J Adv Vet Anim Res; 2023 Jun; 10(2):196-204. PubMed ID: 37534065
[TBL] [Abstract][Full Text] [Related]
12. Profibrotic role of WNT10A via TGF-β signaling in idiopathic pulmonary fibrosis.
Oda K; Yatera K; Izumi H; Ishimoto H; Yamada S; Nakao H; Hanaka T; Ogoshi T; Noguchi S; Mukae H
Respir Res; 2016 Apr; 17():39. PubMed ID: 27071460
[TBL] [Abstract][Full Text] [Related]
13. Lipocalin-2 as a prognostic marker in patients with acute exacerbation of idiopathic pulmonary fibrosis.
Tanahashi H; Iwamoto H; Yamaguchi K; Sakamoto S; Horimasu Y; Masuda T; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
Respir Res; 2024 May; 25(1):195. PubMed ID: 38704585
[TBL] [Abstract][Full Text] [Related]
14. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent.
Wilson MS; Madala SK; Ramalingam TR; Gochuico BR; Rosas IO; Cheever AW; Wynn TA
J Exp Med; 2010 Mar; 207(3):535-52. PubMed ID: 20176803
[TBL] [Abstract][Full Text] [Related]
15. B cell activating factor is central to bleomycin- and IL-17-mediated experimental pulmonary fibrosis.
François A; Gombault A; Villeret B; Alsaleh G; Fanny M; Gasse P; Adam SM; Crestani B; Sibilia J; Schneider P; Bahram S; Quesniaux V; Ryffel B; Wachsmann D; Gottenberg JE; Couillin I
J Autoimmun; 2015 Jan; 56():1-11. PubMed ID: 25441030
[TBL] [Abstract][Full Text] [Related]
16. PD-1 up-regulation on CD4
Celada LJ; Kropski JA; Herazo-Maya JD; Luo W; Creecy A; Abad AT; Chioma OS; Lee G; Hassell NE; Shaginurova GI; Wang Y; Johnson JE; Kerrigan A; Mason WR; Baughman RP; Ayers GD; Bernard GR; Culver DA; Montgomery CG; Maher TM; Molyneaux PL; Noth I; Mutsaers SE; Prele CM; Peebles RS; Newcomb DC; Kaminski N; Blackwell TS; Van Kaer L; Drake WP
Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257954
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice.
Wang Y; Kuai Q; Gao F; Wang Y; He M; Zhou H; Han G; Jiang X; Ren S; Yu Q
Am J Respir Cell Mol Biol; 2019 Dec; 61(6):727-736. PubMed ID: 31162951
[TBL] [Abstract][Full Text] [Related]
18. Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis.
Günther S; Bordenave J; Hua-Huy T; Nicco C; Cumont A; Thuillet R; Tu L; Quatremarre T; Guilbert T; Jalce G; Batteux F; Humbert M; Savale L; Guignabert C; Dinh-Xuan AT
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567353
[TBL] [Abstract][Full Text] [Related]
19. Pre-exposure to Aerosolized Polyvalent Bacterial Lysates Protects Against Bleomycin-Induced Pulmonary Fibrosis in Mice.
Zhu X; Yuan S; Zheng X; Wang X; Zhang J
Inflammation; 2022 Aug; 45(4):1692-1699. PubMed ID: 35249190
[TBL] [Abstract][Full Text] [Related]
20. GLUT1-dependent glycolysis regulates exacerbation of fibrosis via AIM2 inflammasome activation.
Cho SJ; Moon JS; Nikahira K; Yun HS; Harris R; Hong KS; Huang H; Choi AMK; Stout-Delgado H
Thorax; 2020 Mar; 75(3):227-236. PubMed ID: 31822523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
